Related references
Note: Only part of the references are listed.Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum
Vasco Filipe et al.
PHARMACEUTICAL RESEARCH (2012)
Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
Herbert I. Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics
Satish K. Singh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Prediction of Aggregation Prone Regions of Therapeutic Proteins
Naresh Chennamsetty et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: A study by analytical ultracentrifugation
Barthelemy Demeule et al.
ANALYTICAL BIOCHEMISTRY (2009)
Protein Aggregation: Pathways, Induction Factors and Analysis
Hanns-Christian Mahler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality
John F. Carpenter et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
New methods allowing the detection of protein aggregates A case study on trastuzumab
Barthelemy Demeule et al.
MABS (2009)
Nature and consequences of protein-protein interactions in high protein concentration solutions
Atul Saluja et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity
Sonoko Kanai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Epoetin-induced pure red cell aplasia: diagnosis and treatment
Lain C. Macdougall
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2007)
Clinical validation of the in silico prediction of immunogenicity of a human recombinant therapeutic protein
E. Koren et al.
CLINICAL IMMUNOLOGY (2007)
Detection and characterization of protein aggregates by fluorescence microscopy
Barthelemy Demeule et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
High throughput screening of protein formulation stability: Practical considerations
Martinus A. H. Capelle et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Characterization of protein aggregation: The case of a therapeutic immunoglobulin
Barthelemy Demeule et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2007)
Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution
J Liu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Measurement of fluid viscosity at microliter volumes using quartz impedance analysis
A Saluja et al.
AAPS PHARMSCITECH (2004)
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
H Schellekens
CLINICAL THERAPEUTICS (2002)
Bioequivalence and the immunogenicity of biopharmaceuticals
H Schellekens
NATURE REVIEWS DRUG DISCOVERY (2002)
Biosensor analysis of drug-target interactions:: Direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors
R Karlsson et al.
ANALYTICAL BIOCHEMISTRY (2000)
Share Paper
